Melissa Phone.jpg


News and updates about Picomole

Our Team is Growing


Picomole is excited to announce funding approved from the National Research Council of Canada – Industrial Research Assistance Program (NRC IRAP) under their Youth Employment Program. This funding has allowed our team at Picomole to hire an engineer and lab technician to support our engineering team working in the Moncton lab on our breath analytics technology.  

Picomole CEO Participates in Canadian Technology Accelerator Program  


The Canadian Trade Commissioner Service (TCS) is an organization that bridges the gap between Canadian and foreign companies. The TCS has been helping Canadian organizations in the global market for over 120 years and funds the Canadian Technology Accelerator (CTA), a service that is specific to tech companies. 

Picomole Student Interns: Ousman Beebeejaun and Melissa & Melanie Renn  


Picomole is proud of our partnerships with post-secondary academic institutions who provide the opportunity to hire a wealth of emerging talent for student work experiences. Student interns are a great addition to the Picomole team, we benefit from their eagerness to work, learn and we build our pipeline for future permanent hires.  

Ethics Approval for Picomole Lung Cancer Study in Boston  


Picomole is excited to announce a new research project in Boston to detect the presence of lung cancer in breath.  

Researchers will collect samples using Picomole breath sampling technology, samples will be processed and analyzed in the Picomole laboratory to detect the presence of lung cancer identified through the analysis of Volatile Organic Compounds found in the breath. 

NB-IRDT to analyze economics of Picomole lung cancer screening tool 


Picomole has partnered with The New Brunswick Institute for Research, Data and Training (NB-IRDT) at UNB. This project will leverage the expertise and research capability of Picomole and its partners to undertake an economic evaluation of the Picomole lung cancer screening tool.  

Picomole Abstract Published in International Conference


The results of an exciting clinical research study that could help lead to enhancements in the way people are screened for lung cancer have been published as part of a major international conference. Representatives of Picomole Inc., in partnership with Horizon Health Network, recently completed a detailed multi-year study of nearly 200 breath samples collected from lung cancer patients, in addition to healthy subjects.

Branding of Picomole Breath Sampler


Picomole is proud to be working with U-S based marketing firm specializing in life sciences, High Lantern Group, to brand our breath sampling device in anticipation of its commercial launch in early 2021. The project is generously funded by LearnSphere through the Commercialization Consulting and Mentoring (CCM) Program. This project marks the first step in the commercialization of the Picomole Breath Sampler.  

Picomole and UNB Researcher Partner on Algorithm to Detect Lung Cancer


Earlier this week, Robyn Larracy BSc, presented her research on the identification of lung cancer biomarkers at the Digital Breath Biopsy Conference. Ms. Larracy is completing her master's degree in biomedical engineering.  Her master's thesis focuses on the analysis of data generated from Picomole’s Cavity Ring Down Spectroscopy (CRDS) technology.  

Picomole Resumes Sample Collection and Introduces Second Generation Spectrometer

Picomole Inc. is excited to announce that sample collection has commenced again, with the implementation of new COVID-19 protocols. Samples from Horizon Health Network have begun to be Processed at Picomole's laboratory in Moncton, New Brunswick. Picomole is also introducing its second generation analyzer, which allows for quicker and more accurate processing of breath samples.

Picomole Announces Peter Savas as Newest Member of it's Board of Directors



Picomole is excited to add Mr. Savas to its Board. Mr. Savas has extensive experience in the healthcare and life sciences industries, and will bring a wealth of knowledge and experience to Picomole.

Invest in Canada features Picomole as an innovator in the Atlantic Canada medtech industry



Picomole Inc. is honoured to be included in Invest In Canada's Medtech companies in Atlantic Canada to keep an eye on. Picomole continues to strive towards its goal of non-invasive screening method for diseases such as lung cancer. Picomole's breath analytics approach to disease screening will change the way disease is detected for years to come!

Picomole reaches agreement with CRID for regulatory funding



Picomole is pleased to announce that it has reached an agreement with the Centre de Recherche et Innovation Dieppe Inc. (CRID) which will aid Picomole in the rigorous process of regulatory validation for the Picomole Breath Sampler with the FDA and Health Canada 

Picomole receives ethics approval from Horizon for breast cancer proof of concept study

Picomole Inc. is pleased to announce it has received ethi​cs approvals in collaboration with the Horizon Health Network (Horizon), which will allow the Moncton-based company to move ahead with the development of an exciting breast cancer proof of concept study.

Picomole Resumes Sample Collection and Introduces Second Generation Spectrometer



Representatives of Picomole Inc., in partnership with Horizon Health Network and with the help of the New Brunswick Health Research Foundation, recently completed a detailed multi-year study of nearly 200 breath samples collected from lung cancer patients, in addition to healthy subjects. 

Minister of Health Presents Picomole with Funding Award


​Minister of Health, Ginette Petitpas Taylor, presents Picomole funding award

The Honourable Ginette Petitpas Taylor, Minister of Health and Member of Parliament for Moncton-Riverview-Dieppe, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for ACOA announced today that the Government of Canada is providing a total contribution of $818,000 to Picomole through the Atlantic Canada Opportunities Agency (ACOA) and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

BioNova Announces Picomole as the Winner of the Eighth Annual BioInnovation Challenge (BIC) at BioPort 2018

​Today Picomole from Moncton, New Brunswick was named the winner of BioNova’s eighth annual BioInnovation Challenge (BIC) business pitch competition at BioPort 2018.

Dr. Stephen Douglas Graham Appointed CEO of Picomole Inc.

Picomole is excited to announce that Dr. Stephen Graham has been appointed the next CEO of Picomole Inc. Dr Graham will bring a wealth of knowledge to Picomole, as well strong leadership skills to lead the team in the future. Welcome Dr. Graham! 

Stay informed about Picomole.

Sign up to our newsletter to get our latest updates.



191 Halifax Street

Moncton, NB

E1C 9R6

  • Twitter Social Icon
  • LinkedIn Social Icon

©2020  Picomole Inc. All rights reserved.